FEATURED, Neoadjuvant Treatment, Research
ARE WIDER MARGINS NEEDED AFTER NEOADJUVANT CHEMOTHERAPY?
Whereas the “no tumor on ink” paradigm has gained considerable traction in breast-conserving surgery (BCS), there is considerably less data on margins in the ne...
FEATURED, Chemotherapy, Neoadjuvant Treatment, Research
Checkpoint Inhibitor Plus Chemotherapy Dramatically Improves Complete Response Rates Over Chemotherapy Alone in Neoadjuvant Setting
Evading the immune system is mandatory for a tumor to progress. To mount an attack on invading tumor cells, T-cells use a cell surface protein called PD-1 (PD, ...
FEATURED, Neoadjuvant Treatment, News, BRCA, PARP Inhibitors
Neoadjuvant Single-Agent PARP Inhibitor Appears Promising in BRCA Patients
BRCA patients may be able to take only one pill a day in a neoadjuvant setting The results of a small phase II trial suggest that the PARP inhibitor, talazopari...
Cases, Neoadjuvant Treatment, Oncoplastic, Surgery, Techniques
Techniques You Can Use On Monday. A Miami Breast Conference Tradition
Oncoplastic Slides - Download
Subscribe to Updates
TOPICS
- FEATURED (154)
- News (81)
- Research (75)
- Industry (45)
- Opinion (36)
- Risk Assessment (33)
- Genetics (23)
- Breast Cancer (20)
- Genomics (16)
- Cases (14)
- Surgery (14)
- COVID (12)
- Video (12)
- Coding (10)
- Resources (10)
- Genetic Testing (9)
- Neoadjuvant Treatment (9)
- Tools (8)
- Imaging (7)
- Radiation (7)
- Margins (6)
- Biopsy (5)
- Biology (4)
- Chemotherapy (3)
- Oncoplastic (3)
- Risk (3)
- Tumor Localization (3)
- BRCA (2)
- Diagnosis (2)
- Events (2)
- Germline (2)
- Lymphedema (2)
- Metastatic breast cancer (2)
- Regional Management (2)
- Techniques (2)
- Uncategorized (2)
- Biologic Therapy (1)
- CRISPR (1)
- Fertility (1)
- Genetic Engineering (1)
- Health care economics (1)
- Histology (1)
- Neoadjuvant Therapy (1)
- PARP Inhibitors (1)
- Pregnancy (1)
- Subtypes (1)
- links (1)